We are live on
!
Find out more
VF
Virtu Financial Portfolio holdings
AUM
$3.18B
Turnover
77.45%
1-Year Est. Return
65.92%
This Fund
S&P 500
This Quarter
Est. Return
+4.12%
1 Year Est. Return
+65.92%
3 Year Est. Return
+160.27%
5 Year Est. Return
+179.96%
10 Year Est. Return
–
AUM
$2.02B
AUM Growth
+$1.3B
(+180%)
Cap. Flow
+$1.27B
Cap. Flow
% of AUM
62.76%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
2,553
New
2,160
Increased
164
Reduced
123
Closed
87
Avg Time Held Equity + Options
0.1
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$40.3M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$21M |
| 3 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$19.2M |
| 4 |
AF
Astoria Financial Corporation
AF
|
+$18.7M |
| 5 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$18.6M |
| 3 |
OKS
Oneok Partners LP
OKS
|
+$15.5M |
| 4 |
ProShares Short S&P500
SH
|
+$9.57M |
| 5 |
Invesco CurrencyShares British Pound Sterling Trust
FXB
|
+$7.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 57.39% |
| 2 | Financials | 7.24% |
| 3 | Consumer Discretionary | 7% |
| 4 | Healthcare | 6.56% |
| 5 | Technology | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CNXR
2326
DELISTED
Connecture, Inc.
CNXR
| $24K | ﹤0.01% |
+35,481
| New | +$24.9K |
2017 Q3
0 quarters
|
|
2327
Denison Mines
DNN
$2.14B
| $23K | ﹤0.01% |
+49,880
| New | +$23.5K |
2017 Q3
0 quarters
|
|
2328
Lightbridge
LTBR
$179M
| $23K | ﹤0.01% |
+1,706
| New | +$24K |
2017 Q3
0 quarters
|
|
2329
Protara Therapeutics
TARA
$147M
| $23K | ﹤0.01% |
+293
| New | +$16.8K |
2017 Q3
0 quarters
|
|
2330
DELISTED
Double Eagle Acquisition Corp. Warrant
EAGLW
| $23K | ﹤0.01% |
+33,656
| New | +$17.8K |
2017 Q3
0 quarters
|
|
2331
Perspective Therapeutics
CATX
$267M
| $22K | ﹤0.01% |
+4,262
| New | +$23.9K |
2017 Q3
0 quarters
|
|
2332
DELISTED
Vertex Energy, Inc
VTNR
| $22K | ﹤0.01% |
+28,408
| New | +$26K |
2017 Q3
0 quarters
|
|
|
AAU
2333
DELISTED
Almaden Minerals Ltd
AAU
| $22K | ﹤0.01% |
+19,007
| New | +$22.2K |
2017 Q3
0 quarters
|
|
|
KSPN
2334
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
| $22K | ﹤0.01% |
+538
| New | +$19.9K |
2017 Q3
0 quarters
|
|
|
ATIS
2335
DELISTED
Attis Industries Inc. Common Stock
ATIS
| $22K | ﹤0.01% |
+2,166
| New | +$23.3K |
2017 Q3
0 quarters
|
|
|
LINU
2336
DELISTED
LiNiu Technology Group Ordinary Shares
LINU
| $22K | ﹤0.01% |
+20,440
| New | +$31.6K |
2017 Q3
0 quarters
|
|
|
NVIV
2337
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
| $22K | ﹤0.01% |
+1
| New | +$30.7K |
2017 Q3
0 quarters
|
|
|
AXN
2338
DELISTED
Aoxing Pharmaceutical Company Inc.
AXN
| $22K | ﹤0.01% |
+138,411
| New | +$37.8K |
2017 Q3
0 quarters
|
|
|
BSTG
2339
DELISTED
Biostage, Inc. Common Stock
BSTG
| $22K | ﹤0.01% |
+70,685
| New | +$28.3K |
2017 Q3
0 quarters
|
|
2340
Forward Industries Inc
FWDI
$545M
| $21K | ﹤0.01% |
+1,740
| New | +$19.4K |
2017 Q3
0 quarters
|
|
2341
DELISTED
Alimera Sciences
ALIM
| $21K | ﹤0.01% |
+1,037
| New | +$22.2K |
2017 Q3
0 quarters
|
|
|
CGRN
2342
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $21K | ﹤0.01% |
+2,991
| New | +$19.3K |
2017 Q3
0 quarters
|
|
|
KGJI
2343
DELISTED
Kingold Jewelry Inc.
KGJI
| $21K | ﹤0.01% |
+1,740
| New | +$17.9K |
2017 Q3
0 quarters
|
|
|
VRML
2344
DELISTED
Vermillion, Inc.
VRML
| $21K | ﹤0.01% |
+11,416
| New | +$16.8K |
2017 Q3
0 quarters
|
|
2345
DELISTED
DURECT Corp
DRRX
| $20K | ﹤0.01% |
+1,108
| New | +$18.6K |
2017 Q3
0 quarters
|
|
2346
Gulf Resources
GURE
$5.46M
| $20K | ﹤0.01% |
+206
| New | +$18.1K |
2017 Q3
0 quarters
|
|
2347
Jaguar Health
JAGX
$4.47M
| – | – |
0
| – | – |
2017 Q3
0 quarters
|
|
2348
Trilogy Metals
TMQ
$444M
| $20K | ﹤0.01% |
+21,303
| New | +$21.1K |
2017 Q3
0 quarters
|
|
2349
Oruka Therapeutics
ORKA
$4.89B
| $20K | ﹤0.01% |
+81
| New | +$28.8K |
2017 Q3
0 quarters
|
|
2350
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $20K | ﹤0.01% |
+288
| New | +$23.5K |
2017 Q3
0 quarters
|
|
Similar funds
GM
TA
CI
GIA
NSLI
Virtu Financial's Q3 2017 Portfolio in Review
As of Q3 2017, Virtu Financial held 2,553 positions worth $2.02B, up 180% from $721M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Virtu Financial deployed $1.27B of net new capital in Q3 2017, opening 2,160 new positions and adding to 164 existing holdings. Its largest new stake was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, down from 79% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $24.8M trimmed.
- Virtu Financial's largest Q3 2017 buy was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
- Virtu Financial added most to VanEck Gold Miners ETF in Q3 2017, an estimated $40.3M increase.
- Virtu Financial's biggest Q3 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $24.8M.
- Virtu Financial fully exited Oneok Partners LP in Q3 2017, selling an estimated $15.5M.
- Virtu Financial's ten largest holdings make up 17% of its $2.02B portfolio in Q3 2017.
- Virtu Financial opened 2,160 new positions and closed 87 in Q3 2017.
- Virtu Financial's portfolio value rose 180% quarter-over-quarter to $2.02B.
Based on Virtu Financial's 13F filing for Q3 2017, filed 15 Nov 2017.